TCL Archive Dana-Farber Accepts Responsibility For Death Of One Patient, Harm To Another March 31, 1995
TCL Archive The Antineoplaston Anomaly: How A Drug Was Used For Decades In Thousands Of Patients, With No Safety, Efficacy Data September 25, 1998
TCL Archive NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial. April 20, 2007
TCL Archive Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds April 27, 2007
TCL Archive Kennedy Attempts To Establish Unit For All Biomedical Research Similar To Successful Cancer Panel; Administration Threatens Veto March 15, 1974